A randomized, double-blind, placebo-controlled, parallel

Project: Research project

Project Details

Description

A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality
StatusFinished
Effective start/end date8/1/154/30/21

Funding

  • BAYER HEALTHCARE PHARMACEUTICALS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.